Leslie Chong
Chief Executive Officer at IMUGENE LIMITED
Net worth: 5 M $ as of 2024-04-29
Network origin in Leslie Chong first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 27 | |
| Public Company | Biotechnology | 12 | |
Cure Brain Cancer Foundation
 Cure Brain Cancer Foundation Miscellaneous Commercial ServicesCommercial Services Cure Brain Cancer Foundation is a non-profit organization based in Australia that is dedicated to funding innovative brain cancer research. The private company is based in Sydney, Australia. The foundation has invested over $30 million into brain cancer research, including clinical trials and pre-clinical research efforts across pediatric and adult brain cancers. The foundation passionately forges research collaborations, brings world-class clinical trials, and gives people with brain cancer greater access to innovative new treatments. The foundation's mission is to unite the community and rapidly increase brain cancer survival, improving the quality of life for people impacted by the disease, with a vision to ultimately find a cure for brain cancer. The Australian company was founded in 2001. Lance Kawaguchi has been the CEO of the company since 2021.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Leslie Chong via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| CELGENE | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| GENETIC TECHNOLOGIES LIMITED | Biotechnology | Director of Finance/CFO Corporate Secretary Director of Finance/CFO | |
| TOTL BRAI | Medical/Nursing Services | Corporate Secretary Corporate Secretary | |
| ONCOMED PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| RHINOMED | Medical Specialties | Director of Finance/CFO Corporate Secretary Chief Tech/Sci/R&D Officer | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Corporate Officer/Principal Doctorate Degree | |
Mimotopes Pty Ltd.
 Mimotopes Pty Ltd. Pharmaceuticals: OtherHealth Technology Mimotopes Pty Ltd is an industry leader in the peptide and discovery chemistry sector. Mimotopes develops, markets and distributes high quality biochemical products and services for the life-science sector. Their customers range from small labs and universities worldwide, to large multinational drug discovery companies. Their core competence covers the following areas: ' Custom Peptides Mimotopes' custom peptides are synthesized in modern, automated synthesizers using advanced solid phase techniques. The value in using Mimotopes custom peptides is not only that they offer a wide range of peptide lengths, purities and quantities. Their customers can also draw on the exceptional experience of their technical staff, who consult with them to design the peptide application that gives the best possible research outcome. ' PepSets Peptide Libraries Peptide libraries for various screening applications in Proteomics, Immunology and Drug Discovery. PepSets peptide libraries provide researchers with a rapid and cost effective solution for an immense range of bioactivity screening purposes. These sets of custom synthesized peptides enable fast, efficient results. ' Peptide Reagents High-quality amino acids and peptide synthesis reagents. The same reagents that Mimotopes uses in its in-house production system. ' SynPhase Lanterns Modular solid phase supports for organic synthesis, combinatorial chemistry, peptide chemistry, molecule scavenging and affinity applications. Convenient to handle, SynPhase Lanterns are the unique and reliable alternative to using conventional resins for solid-phase synthetic chemistry. Not only do SynPhase Lanterns provide superior reaction kinetics, but their unrivalled ease of handling results in less errors, better traceability and ultimately, faster, more accurate results. | Pharmaceuticals: Other | Director/Board Member | |
Roche Group
 Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Real Estate Development | Corporate Officer/Principal Corporate Officer/Principal | |
| AROVELLA THERAPEUTICS LIMITED | Pharmaceuticals: Major | Chairman Corporate Secretary | |
Monash University
 Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| New York University | College/University | Graduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
| The University of New South Wales | College/University | Undergraduate Degree Doctorate Degree | |
| Vassar College | College/University | Undergraduate Degree | |
| Moscow State University Lomonosov | College/University | Undergraduate Degree | |
| AMBRX INC | Pharmaceuticals: Major | Consultant / Advisor | |
| ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Memorial Sloan Kettering Cancer Center
 Memorial Sloan Kettering Cancer Center Hospital/Nursing ManagementHealth Services Memorial Sloan-Kettering Cancer Center operates as a private cancer center. It offers cancer care services to adult; and child and teen patients. Its services include risk assessment and screening; diagnosis and treatment; clinical trials; patient and caregiver education; and pediatric clinical trials. The company was founded by John J. Astor and Charlotte Astor in 1884 and is headquartered in New York, NY. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Deakin University | College/University | Undergraduate Degree Graduate Degree | |
| RESPIRI LIMITED | Medical Specialties | Director/Board Member Corporate Secretary | |
| ACTINOGEN MEDICAL LIMITED | Pharmaceuticals: Other | Director/Board Member | |
RM Capital Pty Ltd.
 RM Capital Pty Ltd. Investment Banks/BrokersFinance RM Capital Pty Ltd. is an Australian company that combines multiple teams with diverse service offerings and extensive experience. The private company is based in Subiaco, Australia. and has subsidiaries in Australia. The CEO of the company is James B. Richardson. | Investment Banks/Brokers | Analyst-Equity | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Weill Cornell Medical College | College/University | Doctorate Degree | |
| CLOVIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Biotechnology | Corporate Officer/Principal | |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Apexigen America, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. Its product portfolio includes humanized antibodies, targeting diseases such as cancer, inflammatory diseases and ophthalmic disease. The company was founded by Xiao Dong Yang in July 2010 and is headquartered in San Carlos, CA. | Pharmaceuticals: Major | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
RM Research Pty Ltd.
 RM Research Pty Ltd. Investment ManagersFinance RM Research Pty Ltd. (RMR) is the research firm subsidiary of RM Capital Pty Ltd. The firm is headquartered in West Perth, Australia. RMR provides investment research with a focus on emerging mid capitalization mining and energy companies. | Investment Managers | Analyst-Equity | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Director/Board Member | |
| JUNO THERAPEUTICS INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| HEARMEOUT LIMITED | Packaged Software | Director/Board Member | |
| ELSIGHT LIMITED | Computer Communications | Director/Board Member | |
| NEUROSCIENTIFIC BIOPHARMACEUTICALS LIMITED | Biotechnology | Director/Board Member | |
| GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| ROCKETDNA LTD. | Data Processing Services | Director/Board Member | |
Kosmos Capital Pty Ltd.
 Kosmos Capital Pty Ltd. Investment ManagersFinance Kosmos Capital Pty Ltd. is an Independent Private Equity/Venture Capital firm founded in 2017 by Anton Uvarov and Sheridan Hammond. The firm is headquartered in Perth, Australia. | Investment Managers | Founder | |
| NUTRITIONAL GROWTH SOLUTIONS LTD. | Pharmaceuticals: Other | Director/Board Member | |
| RADIOPHARM THERANOSTICS LIMITED | Medical/Nursing Services | Chairman Director of Finance/CFO Corporate Secretary | |
| SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member Chairman | |
Radiopharm Theranostics (USA), Inc.
 Radiopharm Theranostics (USA), Inc. Pharmaceuticals: MajorHealth Technology Radiopharm Theranostics (USA), Inc. is an American company founded in 2021 that develops radiopharmaceutical products for diagnostic and therapeutic uses. | Pharmaceuticals: Major | President Director/Board Member | |
| APEXIGEN, INC. | Biotechnology | Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BLINKLAB LIMITED | Packaged Software | Founder | |
| ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| Australia | 24 |
| United States | 23 |
| Switzerland | 2 |
| Russia | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 10 |
| Finance | 6 |
| Health Services | 4 |
| Technology Services | 4 |
Operational
| Director/Board Member | 107 |
| Corporate Secretary | 93 |
| Corporate Officer/Principal | 66 |
| Chief Tech/Sci/R&D Officer | 58 |
| Director of Finance/CFO | 37 |
Most connected contacts
| Insiders | |
|---|---|
| Justyn Stedwell | 49 |
| Phillip Hains | 43 |
| Paul Hopper | 33 |
| Jens Eckstein | 27 |
| Kimberlee Drapkin | 23 |
| Anton Uvarov | 20 |
| Lesley Russell | 19 |
| Jakob Dupont | 14 |
| Michael Tonroe | 12 |
| Cynthia Elkins | 12 |
| Rita Laeufle | 10 |
| Mark T. Marino | 10 |
| Axel Hoos | 10 |
| Otto Buttula | 10 |
| Syed Rizvi | 9 |
- Stock Market
- Insiders
- Leslie Chong
- Company connections